222 related articles for article (PubMed ID: 32234004)
1. Bortezomib - First Therapeutic Proteasome Inhibitor for Cancer Therapy: A Review of Patent Literature.
Vora PA; Patel R; Dharamsi A
Recent Pat Anticancer Drug Discov; 2020; 15(2):113-131. PubMed ID: 32234004
[TBL] [Abstract][Full Text] [Related]
2. Pemetrexed - First-Line Therapy for Non-Squamous Non-Small Cell Lung Cancer: A Review of Patent Literature.
Vora PA; Patel R; Dharamsi A
Recent Pat Anticancer Drug Discov; 2021; 16(3):333-349. PubMed ID: 33494684
[TBL] [Abstract][Full Text] [Related]
3. Levothyroxine Sodium - Thyroid Hormone Replacement Therapy for Hypothyroidism: A Review of Patent Literature.
Upadhyay U; Vora PA; Patel R; Prajapati B
Recent Pat Biotechnol; 2023; 17(3):245-256. PubMed ID: 36515027
[TBL] [Abstract][Full Text] [Related]
4. Nintedanib as the First Treatment for Group of Progressive Interstitial Lung Diseases: A Review of Patent Literature.
Trivedi MD; Dubal G; Vora PA
Recent Adv Inflamm Allergy Drug Discov; 2023; 17(2):96-109. PubMed ID: 37710999
[TBL] [Abstract][Full Text] [Related]
5. Proteasome inhibitor patents (2010 - present).
Metcalf R; Scott LM; Daniel KG; Dou QP
Expert Opin Ther Pat; 2014 Apr; 24(4):369-82. PubMed ID: 24450483
[TBL] [Abstract][Full Text] [Related]
6. Enhancing the Therapeutic Efficacy of Bortezomib in Cancer Therapy Using Polymeric Nanostructures.
Korani M; Korani S; Zendehdel E; Nikpoor AR; Jaafari MR; Orafai HM; Johnston TP; Sahebkar A
Curr Pharm Des; 2019; 25(46):4883-4892. PubMed ID: 31692424
[TBL] [Abstract][Full Text] [Related]
7. Next-generation proteasome inhibitors for cancer therapy.
Park JE; Miller Z; Jun Y; Lee W; Kim KB
Transl Res; 2018 Aug; 198():1-16. PubMed ID: 29654740
[TBL] [Abstract][Full Text] [Related]
8. Bortezomib in the treatment of cancer.
Roccaro AM; Vacca A; Ribatti D
Recent Pat Anticancer Drug Discov; 2006 Nov; 1(3):397-403. PubMed ID: 18221049
[TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibitors.
Teicher BA; Tomaszewski JE
Biochem Pharmacol; 2015 Jul; 96(1):1-9. PubMed ID: 25935605
[TBL] [Abstract][Full Text] [Related]
10. Bortezomib for the Treatment of Hematologic Malignancies: 15 Years Later.
Robak P; Robak T
Drugs R D; 2019 Jun; 19(2):73-92. PubMed ID: 30993606
[TBL] [Abstract][Full Text] [Related]
11. Emerging Therapeutic Strategies for Overcoming Proteasome Inhibitor Resistance.
Dolloff NG
Adv Cancer Res; 2015; 127():191-226. PubMed ID: 26093901
[TBL] [Abstract][Full Text] [Related]
12. Proteasome inhibitors: structure and function.
Nunes AT; Annunziata CM
Semin Oncol; 2017 Dec; 44(6):377-380. PubMed ID: 29935898
[TBL] [Abstract][Full Text] [Related]
13. The ubiquitin-proteasome system (UPS) and the mechanism of action of bortezomib.
Cvek B; Dvorak Z
Curr Pharm Des; 2011; 17(15):1483-99. PubMed ID: 21504411
[TBL] [Abstract][Full Text] [Related]
14. The role of proteasome inhibition in the treatment of malignant and non-malignant hematologic disorders.
Citrin R; Foster JB; Teachey DT
Expert Rev Hematol; 2016 Sep; 9(9):873-89. PubMed ID: 27447436
[TBL] [Abstract][Full Text] [Related]
15. Preclinical and clinical development of the proteasome inhibitor bortezomib in cancer treatment.
Montagut C; Rovira A; Mellado B; Gascon P; Ross JS; Albanell J
Drugs Today (Barc); 2005 May; 41(5):299-315. PubMed ID: 16082428
[TBL] [Abstract][Full Text] [Related]
16. The proteasome: a novel target for anticancer therapy.
Montagut C; Rovira A; Albanell J
Clin Transl Oncol; 2006 May; 8(5):313-7. PubMed ID: 16760005
[TBL] [Abstract][Full Text] [Related]
17. Dissecting bortezomib: development, application, adverse effects and future direction.
Cao B; Li J; Mao X
Curr Pharm Des; 2013; 19(18):3190-200. PubMed ID: 23151134
[TBL] [Abstract][Full Text] [Related]
18. [Role of novel proteasome inhibitors in the treatment of relapsed/refractory multiple myeloma].
Ri M
Rinsho Ketsueki; 2018; 59(10):2162-2168. PubMed ID: 30305522
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic potential of microbial proteasome inhibitors.
Momose I; Kawada M
Int Immunopharmacol; 2016 Aug; 37():23-30. PubMed ID: 26589840
[TBL] [Abstract][Full Text] [Related]
20. [Proteasome inhibitors in cancer therapy].
Romaniuk W; Ołdziej AE; Zińczuk J; Kłoczko J
Postepy Hig Med Dosw (Online); 2015 Dec; 69():1443-50. PubMed ID: 27259216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
